期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

颅脑损伤患者血清神经元特异性烯醇化酶含量动态变化及其临床意义 被引量：2

下载PDF
导出
作者 李银琦 王学蛟 段虎斌 杨晓明
机构地区 山西医科大学 山西医科大学第一医院
出处 《山西医药杂志（上半月）》 CAS 2008年第4期348-349,共2页 Shanxi Medical Journal
基金 国家自然科学基金资助项目(30600637)
关键词 神经元特异性烯醇化酶 颅脑损伤患者 酶含量 临床意义 动态变化 中枢神经系统损害 天冬氨酸转氨酶 血清
分类号 R651.1 [医药卫生—外科学]
  • 相关文献

参考文献6

  • 1[1]Skogseid ZM,Nordby HK.Vrdal P.et al.Inceased seru creatine kinase BB and neueon specific anolase following head iniumy indi cates brain dsmage.Aeta Neuroehir(Wein),1992,115:106-111.
  • 2王淑贞,马驰骋,曹丽丽,魏汝云,迟兆富.老年脑卒中患者血清神经元特异性烯醇化酶的测定及意义[J].中国老年学杂志,2006,26(3):410-411. 被引量：24
  • 3[3]Schaarsschmidt H,Prange HW,Reiber H.Neuron specific enolase concentration in blood as a prgnostie parameter in cerebrovascular diseases.Stroke,1994.25:558.
  • 4[4]rabinowiez AL,Correale JD,Bracht KD,et al.Neuron specific enolase is increased after nonconvalsive status epilepticus.Epilepsia,1995,36(2):475.
  • 5[5]Wocktgem C,Roberil RD.Neuron sgecific enolase serum levels af tel-controned corial impact injury in the rat.Neurotrum.2001.8(5):569-573.
  • 6[6]Takahashi M,Charnczuk A,Hong Y,et al.Rapid and sensitie im munoassay for the measurement of serum S 100 using isoform-spe cific monoclonal antibody.Clin Chem,1999,45:1307-1310.

二级参考文献9

  • 1Wunder MT,Ebert AD,Kratz T,et al.Early neurobehavioral outcome after stroke is related to release of neurobiochemical marker of brain damage[J].Stroke,1999,30(6):1190-5.
  • 2Kittaka M,Ciannotta SL,Zelman V,et al.Attenuation of brain injury and reduction of neuro-specific enolase by nicardipine in systemic circulation following focal ischemic and reperfusion in a rat model[J].Neurotrauma,1997,87(5):731-7.
  • 3Woetrgen C,Rothoerl RD,Brawanski A.Neuron-specific enolase serum levels after controlled cortical impact injury in the rat[J].Neurotrauma,2001 ,18(5):569-73.
  • 4Lee JG,Oh SH,Na SJ,et al.The effect of initial serum neuro-specific enolase lever on clinical outcome in acute carotid artery territory infarction[J].J Yonsei Med,2002, 43 (3):357-62.
  • 5Wunderlich MT,Ebert AD,Kratz TY,et al.Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage[J].Stroke,1999 ,30:1190.
  • 6Persson L,Hardemark HG,Gustafsson J,et al.S-100 protein and neurospecific enolase in cerebrospinal fluid and serum:marker of cell damage in human central nervous system[J].Stroke,1998, 18:911-8.
  • 7Marters P,Rabe A,Johnsson P,et al.Serum S-100 protein and neuro-specific enolase for prediction of regaining ischemic[J].Stroke,1998, 29(11):2363.
  • 8邢永前,王义刚,赵斌,黄迪南,陈小江,夏绪刚,郑华,韩陈保,张俊徽,尹小健,侯敢,梁学标.115例脑卒中患者血清神经元特异性烯醇化酶测定及其意义[J].中国神经免疫学和神经病学杂志,2001,8(1):29-31. 被引量：13
  • 9季海生,杨爱,陈希莲,陈永生,蒋建章.急性脑卒中血清神经元特异性烯醇化酶与NO的相关研究[J].陕西医学检验,2001,16(1):6-9. 被引量：14

共引文献23

同被引文献22

  • 1葛忆秦,程英.急性颅脑损伤患者血清S100B蛋白动态检测的意义[J].南通大学学报（医学版）,2008,28(3):185-186. 被引量：7
  • 2梅杰,张光辉.颅脑损伤对机体免疫功能的影响[J].中国临床神经外科杂志,2005,10(3):237-239. 被引量：10
  • 3袁向东.急性脑挫伤患者血清神经元特异性烯醇化酶的变化及其临床意义[J].实用医学杂志,2006,22(17):1988-1989. 被引量：5
  • 4De Giorgio C M,Gott P S,Rabinowicz A L,et al. Neuron-specific enolase, a marker of acute neuronal injury, is increased in complex partial status epilepticus [ J ].Epilepsia, 1996,37 (7) : 606-609.
  • 5Pineda J A, Wang K K, Hayes R L.Biomarkers of proteolytic damage following traumatic brain injury[J].Brain Pathol, 2004, 14(2) :202.
  • 6Vos P E, Lamers K J, Hendriks J C, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury [J]. Neurology,2004,62(8): 1303.
  • 7Dietrich WD, Bramlett HM. The evidence for hypothermia as a neuroprotectant in traumatic brain injury. Neurotherapeutics, 2010, 7:43-50.
  • 8Maas AI, Roozenbeek B, Manley GT. Clinical trials in traumatic brain injury : past experience and current developments. Neurotherapeutics, 2010, 7 : 115-126.
  • 9Li H, Lu G, Shi W, et al. Protective effect of moderate hypothermia on severe traumatic brain injury in children. J Neurotrauma, 2009,26 : 1905-1909.
  • 10Borlongan CV, Emerich DF. Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport. Brain Res Bull,2003,60:297-306.

引证文献2

二级引证文献21

山西医药杂志（上半月）
2008年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部